FASLG and systemic lupus erythematosus: Third, clinically heterogeneous data due to enrolment (PAPS, SLE-aPL positive, aPL positive) may have led to different therapeutic approaches that impacted the renal outcome, opening the strong possibility of bias and making the quality of most studies in this meta-analysis low.